Supplementary Table S1 from The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Authors :: Geoffrey I. Shapiro
Alan D. D'Andrea
Joyce F. Liu
Ursula A. Matulonis
Panagiotis A. Konstantinopoulos
Khanh T. Do
Lee Zou
Connor E. Dunn
Hunter D. Reavis
Elizaveta Reznichenko
Anniina Färkkilä
Larissa A. Sambel
Chunyu Yang
Paul T. Kirschmeier
Sangeetha Palakurthi
Zhigang C. Wang
Jean-Bernard Lazaro
Bose S. Kochupurakkal
Kalindi Parmar
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Characterization of high-grade serous ovarian cancer models

Full Text Access

Tools